BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

Liwei Zhao(Inserm), Guido Kroemer(Inserm)
Cancer Discovery
August 24, 2023
Cited by 69


Related Papers